Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies Inc. Message Board

  • amlnlover100 amlnlover100 Jul 8, 2013 7:40 AM Flag

    Not Monkying Around

    Data from CMX001-201 Trial in Hematopoietic Stem Cell Transplant patients presented in Late-Breaking Poster Session at 24th International Congress of The Transplantation Society

    "Herve Mommeja-Marin, MD, Vice President of Clinical Research at Chimerix, presented the BKV data from the Phase 2 Study CMX001-201, which had as its primary objective the evaluation of CMX001 versus placebo for the prevention of cytomegalovirus (CMV) infection in 230 HSCT recipients. Phase 2 results presented elsewhere have shown that CMX001, at various doses, was active and well-tolerated in the prevention of CMV infection or disease. "

 
SIGA
2.460.00(0.00%)Mar 13 4:00 PMEDT